🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, non-randomized study of the safety and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00934856
Treatments Being Tested
The investigators will conduct a prospective phase 2 study to evaluate the ...
Status
Not Yet Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-06-19
Trial ID
NCT06469060
Treatments Being Tested
Azacitidine can reverse clinical resistance to docetaxel through upregulati...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00503984
The standard treatment strategy of locally advanced nasopharyngeal carcinom...
Status
Unknown
Location
Cancer Center of Guangzhou Medical University
Start Date
2015-08
Trial ID
NCT02512315
Treatments Being Tested
The purpose of this study is to determine the effectiveness of the combinat...
Status
Terminated
Location
Gynecologic Oncology Research & Development, LLC
Start Date
2005-04
Trial ID
NCT00285415
Treatments Being Tested
ADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patie...
Status
Recruiting
Location
Klinikum Mittelbaden, Brustzentrum
Start Date
2024-02-05
Trial ID
NCT05704829
Treatments Being Tested
Arm1- bevacizumab (Onbevzi) at a dose of 15 mg/kg administered as a 30-minu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07547592
Treatments Being Tested
The primary objective of this trial is to compare the rate of pathologicall...
Status
Completed
Location
German Breast Group
Start Date
TBD
Trial ID
NCT00793377
Breast cancer is the most common malignant tumor in women. EC-TH is one of ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2019-01-10
Trial ID
NCT04172259
RATIONALE: Drugs used in chemotherapy, such as epirubicin, cyclophosphamide...
Status
Completed
Location
Universitaetsfrauenklinik Frankfurt
Start Date
2005-01
Trial ID
NCT00288002